The use of PDT after EGFR-CPIG and anti-PD-L1 antibodies IV administration in a CRC murine model demonstrated a synergistic action of these two therapies combined, causing complete tumor eradication with no relapses over time. The gene discussed is EGFR; the disease is colorectal carcinoma.